ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 55 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,883,000 | -22.9% | 1,108,658 | +15.3% | 0.00% | 0.0% |
| Q3 2016 | $3,740,000 | +50.9% | 961,334 | +4.3% | 0.00% | 0.0% |
| Q2 2016 | $2,479,000 | +941.6% | 921,567 | +1090.6% | 0.00% | – |
| Q1 2016 | $238,000 | -25.9% | 77,402 | -7.2% | 0.00% | – |
| Q4 2015 | $321,000 | -85.0% | 83,384 | -88.1% | 0.00% | -100.0% |
| Q3 2015 | $2,137,000 | -23.5% | 700,736 | +6.4% | 0.00% | 0.0% |
| Q2 2015 | $2,793,000 | -43.0% | 658,620 | -48.1% | 0.00% | 0.0% |
| Q1 2015 | $4,900,000 | -40.3% | 1,269,538 | +4.2% | 0.00% | -50.0% |
| Q4 2014 | $8,202,000 | +32.5% | 1,218,745 | +8.1% | 0.00% | 0.0% |
| Q3 2014 | $6,192,000 | -45.9% | 1,127,877 | +1.1% | 0.00% | -33.3% |
| Q2 2014 | $11,438,000 | -19.0% | 1,115,876 | -5.1% | 0.00% | -25.0% |
| Q1 2014 | $14,115,000 | +10.8% | 1,175,245 | +4.3% | 0.00% | 0.0% |
| Q4 2013 | $12,740,000 | +79.0% | 1,126,469 | +70.6% | 0.00% | +100.0% |
| Q3 2013 | $7,116,000 | +47.4% | 660,130 | +26.7% | 0.00% | 0.0% |
| Q2 2013 | $4,828,000 | – | 520,871 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINCOLN CAPITAL CORP | 34,250 | $116,000 | 0.11% |
| Kovack Advisors, Inc. | 24,393 | $82,000 | 0.02% |
| Cedar Wealth Management, LLC | 12,000 | $41,000 | 0.02% |
| Ausdal Financial Partners, Inc. | 19,590 | $66,000 | 0.02% |
| HRT FINANCIAL LP | 15,990 | $53,000 | 0.02% |
| Granite Investment Partners, LLC | 53,853 | $182,000 | 0.01% |
| Joel Isaacson & Co., LLC | 20,000 | $68,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 53,658 | $181,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 246,150 | $831,000 | 0.01% |
| Dynamic Technology Lab Private Ltd | 15,108 | $51,000 | 0.01% |